Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U-Stem Biomedical is a Taiwan-based biotechnology company specializing in regenerative medicine and tissue engineering. The company focuses on developing advanced solutions for bone repair and dental applications, leveraging its proprietary stem cell processing and biomaterial platforms. Their product portfolio includes bone graft substitutes and regenerative membranes designed to enhance healing in orthopedic and dental surgeries. U-Stem aims to integrate cell therapy with biocompatible materials to provide comprehensive clinical solutions for tissue regeneration. The company is a spin-off from research conducted at National Tsing Hua University, emphasizing the translation of academic innovation into clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U-Stem Biomedical.